These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38879633)

  • 1. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies.
    Dellarole IL; Vacchi E; Ruiz-Barrio I; Pinton S; Raimondi A; Rossi S; Morandi S; Bianco G; Begum Bacinoglu M; Lombardo A; Celauro L; Staedler C; Galati S; Pagonabarraga J; Kulisevsky J; Legname G; Gobbi C; Kaelin-Lang A; Moda F; Melli G
    NPJ Parkinsons Dis; 2024 Jun; 10(1):116. PubMed ID: 38879633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
    Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
    Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies.
    Wang Z; Wu L; Gerasimenko M; Gilliland T; Gunzler SA; Donadio V; Liguori R; Xu B; Zou WQ
    Res Sq; 2024 Mar; ():. PubMed ID: 38496453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.
    Fernandes Gomes B; Farris CM; Ma Y; Concha-Marambio L; Lebovitz R; Nellgård B; Dalla K; Constantinescu J; Constantinescu R; Gobom J; Andreasson U; Zetterberg H; Blennow K
    Parkinsonism Relat Disord; 2023 Dec; 117():105807. PubMed ID: 37591709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
    Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
    ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
    Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
    Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
    Yoshida M
    Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
    Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.
    Saijo E; Metrick MA; Koga S; Parchi P; Litvan I; Spina S; Boxer A; Rojas JC; Galasko D; Kraus A; Rossi M; Newell K; Zanusso G; Grinberg LT; Seeley WW; Ghetti B; Dickson DW; Caughey B
    Acta Neuropathol; 2020 Jan; 139(1):63-77. PubMed ID: 31616982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.
    Wang Z; Gilliland T; Kim HJ; Gerasimenko M; Sajewski K; Camacho MV; Bebek G; Chen SG; Gunzler SA; Kong Q
    medRxiv; 2024 Jun; ():. PubMed ID: 38978648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer's disease brain.
    Frey B; Holzinger D; Taylor K; Ehrnhoefer DE; Striebinger A; Biesinger S; Gasparini L; O'Neill MJ; Wegner F; Barghorn S; Höglinger GU; Heym RG
    Acta Neuropathol Commun; 2023 Nov; 11(1):181. PubMed ID: 37964332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy.
    De Luca CMG; Elia AE; Portaleone SM; Cazzaniga FA; Rossi M; Bistaffa E; De Cecco E; Narkiewicz J; Salzano G; Carletta O; Romito L; Devigili G; Soliveri P; Tiraboschi P; Legname G; Tagliavini F; Eleopra R; Giaccone G; Moda F
    Transl Neurodegener; 2019; 8():24. PubMed ID: 31406572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Giannoccaro MP; Avoni P; Rizzo G; Incensi A; Infante R; Donadio V; Liguori R
    J Parkinsons Dis; 2022; 12(2):585-591. PubMed ID: 34864689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R.
    Sandberg A; Ling H; Gearing M; Dombroski B; Cantwell L; R'Bibo L; Levey A; Schellenberg GD; Hardy J; Wood N; Fernius J; Nyström S; Svensson S; Thor S; Hammarström P; Revesz T; Mok KY
    Neurobiol Dis; 2020 Dec; 146():105079. PubMed ID: 32961270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Vaughan DP; Fumi R; Theilmann Jensen M; Hodgson M; Georgiades T; Wu L; Lux D; Obrocki R; Lamoureux J; Ansorge O; Allinson KSJ; Warner TT; Jaunmuktane Z; Misbahuddin A; Leigh PN; Ghosh BCP; Bhatia KP; Church A; Kobylecki C; Hu MTM; Rowe JB; Blauwendraat C; Morris HR; Jabbari E
    Mov Disord; 2024 Sep; ():. PubMed ID: 39301998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.